Journals / Arşiv Kaynak Tarama Dergisi / 2019 / Cilt: 28 - Sayı: 4

Local and Systemic Renin Angiotensin System

Lokal ve Sistemik Renin Anjiyotensin Sistemi

Pages
259–269
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, full identification of local RAS components will play an important role in the development of new treatment modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Renin Angiotensin System (RAS) has been reported to play an important role in the physiopathology of cardiovascular diseases such as atherosclerosis and hypertension.
📊
Key Findings & Data:Interaction of vascular smooth muscle and endothelial cells with RAS, lipoproteins and insulin has been shown to cause the development and progression of diseases such as diabetes, myocardial infarction, hypertension, stroke and stent restenosis.
💡
Conclusion & Impact:Thus, full identification of local RAS components will play an important role in the development of new treatment modalities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The Renin Angiotensin System (RAS) has been reported to play an important role in the physiopathology of cardiovascular diseases such as atherosclerosis and hypertension. Interaction of vascular smooth muscle and endothelial cells with RAS, lipoproteins and insulin has been shown to cause the development and progression of diseases such as diabetes, myocardial infarction, hypertension, stroke and stent restenosis. While systemic RAS is mostly responsible for the regulation of blood pressure, salt and water intake, release of antidiuretic hormone (ADH), local RAS plays a role in the proliferation, growth, apoptosis and inflammation of vascular smooth muscle cells. In studies, it has been shown that RAS components are synthesized locally in many places such as vascular smooth muscle, heart cells, fat tissue and brain. Thus, full identification of local RAS components will play an important role in the development of new treatment modalities.

Özet

Renin Anjiyotensin Sisteminin (RAS) atheroskleroz ve hipertansiyon gibi kardiyovasküler hastalıklarınfizyopatolojisinde önemli rol oynadığı bildirilmektedir. Vasküler düz kas ve endotel hücresinin RAS, lipoproteinler veinsülinle etkileşimi, diyabet, miyokart enfarktüs, hipertansiyon, inme ve stent restenozu gibi hastalıkların gelişimine veilerlemesine neden olarak gösterilmektedir. Sistemik RAS daha çok kan basıncının düzenlenmesini, tuz ve su alımını,antidiüretik hormon (ADH) salınımını sağlarken, lokal RAS vasküler düz kas hücrelerinin çoğalması, büyümesi,apopitoz ve inflamasyonunda görev almaktadır. Çalışmalarda, RAS bileşenlerinin vasküler düz kas, kalp hücresi, yağdokusu ve beyin gibi birçok yerde lokal olarak sentezlendiği gösterilmiştir. Vasküler yapı üzerine hem sistemik hem delokal olarak sentez edilip etki gösteren RAS’ın patolojik süreçlerdeki intrasellüler etki mekanizmaları tam olarakaydınlatılamamıştır. Bu yüzden lokal RAS’ın bileşenlerinin tam anlamıyla aydınlatılması yeni tedavi yöntemleriningeliştirilmesinde önemli rol oynayacaktır

🔖

Cite This Article

ÇİÇEK, Z., AKILLIOĞLU, K., DOĞAN, A. (2022). Local and Systemic Renin Angiotensin System. Arşiv Kaynak Tarama Dergisi, Cilt: 28 - Sayı: 4, 259–269. https://ajindex.com/articles/449157

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. Journal of internal medicine. 2008;264:224-36
  2. Hussain M, Awan FR. Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease. Clinical and experimental hypertension. 2018;40:344-52
  3. Schmidt-Ott KM, Kagiyama S, Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regulatory peptides. 2000;93:65-77
  4. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American journal of physiology Cell physiology, 2007;292:C82-97
  5. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clinical science, 2007;112:417-28
  6. Abuissa H, Jones PG, Marso SP, O'Keefe JH, Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. Journal of the American College of Cardiology. 2005;46:821-6
  7. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2002;35:1001-15
  8. Kim E. Barrett P, Scott Boitano P, Susan M. Barman P, Heddwen L. Brooks P. Ganong's Review of Medical Physiology McGraw-Hill Education. 2016
  9. Bihl JC, Zhang C, Zhao Y, Xiao X, Ma X, Chen Y, Chen S, Zhao B, Chen Y. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFsmall ka, CyrillicB inflammatory pathway. Vascular pharmacology. 2015;73:115-23
  10. Guo DF, Sun YL, Hamet P, Inagami T. The angiotensin II type 1 receptor and receptor-associated proteins. Cell research. 2001;11:165-180
  11. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P ve Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2001;15:2727-9
  12. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. Journal of the American College of Cardiology. 1996;28:803-12
  13. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747-803
  14. Kumar R, Singh